We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmakers Pledge to Cooperate with Oversight Committee’s Drug Pricing Investigation
Drugmakers Pledge to Cooperate with Oversight Committee’s Drug Pricing Investigation
Drugmakers are pushing back against claims by newly-seated House Oversight Committee Chair Elijah Cummings (D-Md.) about their drug pricing practices, but say they will cooperate with the committee’s investigation.